Full Press Release Details
Biogen Idec, Columbia University and HudsonAlpha Institute Identify New ALS Gene and Signaling Pathways.
BIIB
Biogen Idec, Columbia University and HudsonAlpha Institute Identify New ALS Gene and Signaling Pathways
Key Takeaway: Biogen Idec, Columbia University and HudsonAlpha Institute Identify New ALS Gene and Signaling Pathways
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis